1. Medtech Insight
  2. >>Device Area
  3. >>Surgery
  4. >>Surgical Procedures

Market Intel: EU Ortho Close-Up: Rising, But Varying Orthopedic/Spinal Opportunities In 5 European Markets

 
• By Marion Webb

A rising and more active aging population, and a growing incidence of osteoporosis fractures and back pain – as well as other spine-related issues – are paving the way for companies to bring innovative devices into the hands of orthopedic and spinal surgeons in Spain, Italy, Germany, the UK and France. In this feature, we take a closer look at the prevailing surgical approaches and techniques for selected fracture fixation, spinal surgery procedures, joint replacement, and arthroscopy procedures in each of the five major EU countries, as outlined in a new Meddevicetracker report. We also take a deep dive into the various growth opportunities of select procedures in each EU market and discuss trends.

MT1712_Orthopedic_536308798_1200.jpg

With its sizeable population, advanced national economies and modern health-care systems, Europe is one of the world's largest and most profitable markets for medical products manufacturers. To compete effectively, manufacturers need to become familiar with the health-care funding, reimbursement practices and regulatory requirements of the European Union, according to Meddevicetracker's "European Surgical Procedure Volumes: Orthopedic and Spine Procedures" report.

While the report offers a detailed view of the unique health-care economies of the five EU countries – Germany, the UK, Italy, Spain and France – this article focuses on the prevailing surgical approaches in fracture fixation, spinal surgery procedures, joint replacement and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Surgical Procedures

SS Innovations Files For De Novo For SSi Mantra 3 Surgical Robotic System For Multispecialty Indications

 
• By Marion Webb

SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 
• By Brian Bossetta

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.

AAOS 2025 Orthopedic Roundup: J&J Velys UKA, Stryker Mako 4, Materialise, Canary Medical

 
• By Marion Webb

At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 
• By Brian Bossetta

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

More from Surgery

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 
• By Brian Bossetta

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

HRS Released Framework For Afib Center Of Excellence To Improve Outcomes Through Multidisciplinary Care

 
• By Marion Webb

Medtech Insight sat down with Jared Bunch, chair of AF Center of Excellence Task Force, at HRS 2025 to discuss the newly HRS released framework for Afib Center of Excellence and get his perspective on the role industry could play to help clinicians improve patient outcomes.

Q’Apel Medical Recalls, Discontinues Stroke Therapy System After FDA Warning Letter, Class I Designation

 
• By Brian Bossetta

Q’Apel Medical has pulled its aspiration system for stroke thrombectomy from the market after concerns raised by the US FDA in a February warning letter.